IP Library Granted Patent US 8,734,864
Granted Patent B2
US 8,734,864 · App. 13/623,114 · Granted May 27, 2014

Methods for increasing human growth hormone levels

Inventors: Amy L. Heaton (Salt Lake City, UT); Mitchell K. Friedlander (Salt Lake City, UT); Dennis Gay (Salt Lake City, UT)
Assignee: Quality IP Holdings, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,734,864
App. No.
13/623,114
Granted
May 27, 2014
Kind
B2
Abstract

Embodiments of the invention generally relate to methods and supplements for increasing human growth hormone (hGH) levels in healthy human beings.

Claims (32)

1. A method of increasing human growth hormone in a healthy human being, the method comprising:

orally administering to the human being an effective amount of a nutritional supplement, wherein the nutritional supplement consists of:

about 1 mmol L-arginine;

about 1 mmol Oxo-proline;

about 2 mmol L-lysine;

about 1.5 μmol N-acetyl L-cysteine; and

about 125 μg Schizonepta (aerial parts) powder.

2. The method of claim 1 , wherein the L-lysine is delivered as a non-toxic salt of the L-lysine, a complex of the L-lysine, a stable chelate of the L-lysine, an ester of the L-lysine, a derivative of the L-lysine, or mixtures thereof.

3. The method according to claim 1 , wherein 2.9 grams of the nutritional supplement is administered to the human being.

4. The method of claim 1 , wherein the nutritional supplement is in powder, tablet, capsule, liquid, or wafer form.

5. The method of claim 1 , wherein the nutritional supplement is administered from one to three times daily.

6. The method of claim 1 , wherein the nutritional supplement is administered once a week.

7. The method of claim 1 , wherein the nutritional supplement is administered on an empty stomach.

8. The method of claim 1 , wherein orally administering the nutritional supplement to a healthy human being comprises orally administering the nutritional supplement to a healthy female human.

9. The method of claim 1 , wherein orally administering the nutritional supplement to a healthy human being comprises orally administering the nutritional supplement to a healthy male human that is at least 30 years of age.

10. The method of claim 1 , wherein orally administering the nutritional supplement to a healthy human being comprises orally administering the nutritional supplement to a healthy human of at least 30 years of age.

11. A method of increasing human growth hormone in a healthy human being, the method comprising:

orally administering to the human being an effective amount of a nutritional supplement, wherein the nutritional supplement consists of:

3.44 mmol L-arginine;

5.30 mmol Oxo-proline;

8.21 mmol L-lysine;

6.13 μmol N-acetyl L-cysteine;

6.84 μmol L-glutamine; and

0.50 mg Schizonepta (aerial parts) powder.

12. The method according to claim 11 , wherein 2.9 grams of the nutritional supplement is administered to the human being.

13. The method of claim 11 , wherein the nutritional supplement is in powder, tablet, capsule, liquid, or wafer form.

14. The method of claim 11 , wherein the nutritional supplement is administered from one to three times daily.

15. The method of claim 11 , wherein the nutritional supplement is administered once a week.

16. The method of claim 11 , wherein the nutritional supplement is administered on an empty stomach.

17. The method of claim 11 , wherein orally administering the nutritional supplement to a healthy human being comprises orally administering the nutritional supplement to a healthy female human.

18. The method of claim 11 , wherein orally administering the nutritional supplement to a healthy human being comprises orally administering the nutritional supplement to a healthy male human that is at least 30 years of age.

19. The method of claim 11 , wherein orally administering the nutritional supplement to a healthy human being comprises orally administering the nutritional supplement to a healthy human of at least 30 years of age.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Jan 5, 2023
From: CASPAR CAPITAL LP
To: QUALITY IP HOLDINGS LLC
Reel/Frame 062283/0073 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 2, 2022
From: CERBERUS BUSINESS FINANCE, LLC
To: CASPAR CAPITAL LP
Reel/Frame 061636/0625 →
ASSIGNMENT OF SECURITY INTEREST Recorded Dec 30, 2019
From: LS2, LLC
To: CERBERUS BUSINESS FINANCE, LLC
Reel/Frame 051447/0114 →
SECURITY INTEREST Recorded Aug 21, 2015
From: QUALITY IP HOLDINGS, LLC
To: LS2, LLC
Reel/Frame 036392/0053 →
ASSIGNMENT FOR SECURITY - PATENTS Recorded Dec 4, 2014
From: QUALITY IP HOLDINGS, LLC
To: CERBERUS BUSINESS FINANCE, LLC, AS COLLATERAL AGENT
Reel/Frame 034535/0294 →
CORRECTIVE ASSIGNMENT TO CORRECT THE NAME OF ASSIGNEE, PREVIOUSLY RECORDED ON REEL 032089 FRAME 0885. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 26, 2014
From: HEATON, AMY L.; FRIEDLANDER, MITCHELL K.; GAY, DENNIS
To: QUALITY IP HOLDINGS, LLC
Reel/Frame 033617/0120 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 30, 2014
From: HEATON, AMY L.; FRIEDLAND, MITCHELL K.; GAY, DENNIS
To: QUALITY IP HOLDINGS, INC.
Reel/Frame 032089/0885 →
Continuity (1)
Related Publication 20140079828A1 · Mar 20, 2014